Pricing Log in Create free account

Axsome Therapeutics, Inc. (AXSM) vs Mirum Pharmaceuticals, Inc. (MIRM)

Axsome Therapeutics, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. is the larger, with a market value of $6.8B against $6.1B — 1.1× the size. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 54.2% against 42.2%. Axsome Therapeutics, Inc. has the higher net margin (−18.2% vs −134.8%) and the higher return on invested capital (0.00% vs −184.7%). Across the 16 metrics below, Axsome Therapeutics, Inc. leads on 12 and Mirum Pharmaceuticals, Inc. on 4.

Valuation

Metric AXSM MIRM Biotechnology median
P/E n/m n/m 10.26
P/S 7.83 9.18 9.18
P/B 64.25 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 7.61 9.72 8.98
Earnings yield (2.37%) (16.19%) (34.89%)
Free cash flow yield (1.22%) (5.01%) (24.52%)

Profitability

Metric AXSM MIRM Biotechnology median
Gross margin 93.25% 81.72% 65.16%
Operating margin (17.45%) (133.62%) 0.00%
Net margin (18.18%) (134.75%) 0.00%
Free cash flow margin (9.55%) (46.04%) 0.00%
Return on equity (175.59%) (760.01%) (50.12%)
Return on assets (21.03%) (99.78%) (45.60%)
Return on invested capital 0.00% (184.65%) 0.00%

Growth

Metric AXSM MIRM Biotechnology median
Revenue growth (TTM) 54.16% 42.18% 6.26%
EPS growth (last fiscal year) 38.56% 74.59% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AXSM MIRM Biotechnology median
Debt to equity 1.21 (13.50) 0.00
Current ratio 1.42 2.07 4.89
Net debt to EBITDA 1.29 (19.11) 1.01

Dividend

Metric AXSM MIRM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AXSM MIRM Biotechnology median
Market cap 6.83b 6.11b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack